Research Highlights - Promise Summer 2017 Discoveries and Achievements Downing, Mullighan receive national awards James R. Downing, M.D., and Charles Mullighan, MBBS, M.D., have received awards from prestigious cancer research institutions. Researchers unlock immunity ‘black box’ The immune machinery that drives the skin disease neutrophilic dermatosis (Sweet’s syndrome) reveals clues for taming the immune response Discovery offers clues to cancer’s origins Epigenetic map reveals molecular switches that control development of both the normal retina and the eye cancer retinoblastoma. From Promise, Summer 2017 Donate Now Promise Archive First name: Last name: Email: Message: Submit Feedback Thank you for your feedback! More articles from this issue Leukemia and Lymphoma: The TOTAL Package A new precision medicine study aims to push leukemia and lymphoma survival rates ever higher while reducing side effects. Sean Kenney: A Mission-driven Life Find out how brain tumor survivor Sean Kenney found inspiration at St. Jude and has become an international advocate for refugees. St. Jude Biorepository: A Hope Chest of Cells St. Jude patients donate tissue to the biorepository in hopes that their preserved biological samples will be used in groundbreaking cancer research. A Plan Unfolds for Accelerating Progress James R. Downing, MD, president and chief executive officer, is heading a six-year, $7 billion strategy to accelerate progress toward curing childhood cancer. Finding the Magic in Cell Death Millions of cells in our bodies die each day. By unveiling the mysteries of cell death, scientists offer options for patients of all ages. Volunteers Find Time to Shine St. Jude Walk/Run chair finds volunteers through social media and matches their strengths to a position to form the best volunteer leadership team possible. The St. Jude Garden of Eatin’ The St. Jude Garden provides nutrient-packed food for patients and a delicious respite for volunteers and visitors. Donald Pinkel, MD: Celebration of a Legacy St. Jude pays homage to its first director and CEO by dedicating the Donald P. Pinkel, MD, Research Tower. The Power of Science Even after leaving St. Jude, a former faculty member recognizes the innovative work being done in sickle cell disease and helps fund research at the hospital. Survivor Heeds a Calling to Care For childhood cancer survivor Ashley McTyre, RN, nursing is not a career, but a calling. Top billing from U.S. News & World Report St. Jude Children’s Research Hospital was recently ranked as the nation’s No. 1 pediatric cancer hospital in the “Best Children’s Hospitals” list.